Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
486 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05917990 | Dyadic Text-Messaging Micro-Intervention | withdrawn | N/A | 0 | Duke UniversityOTHER | 1 | Jul 28, 2025 | clinicaltrials |
| NCT06468605 | Safety, Tolerability and Efficacy of JCXH-211 in Patients With Recurrent or Progressive High-Grade Glioma(SERIL) | withdrawn | Phase 1 | 0 | Duke UniversityOTHER | 0 | Jul 23, 2025 | clinicaltrials |
| NCT04352777 |
| Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer |
| completed |
| Phase 2 |
| 18 |
| Duke UniversityOTHER |
| 1 |
| Jul 20, 2025 |
| clinicaltrials |
| NCT06834945 | Addressing Fertility Information Needs and Distress | completed | N/A | 24 | Duke UniversityOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT04569461 | Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)(TALON) | withdrawn | Phase 2 | 0 | Duke UniversityOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT04035447 | Symptom Management for YA Cancer Survivors | completed | N/A | 65 | Duke UniversityOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT04998318 | 1:1 Comparison of the Pocket Colposcope in Kenya | completed | N/A | 434 | Duke UniversityOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT04567251 | Survivorship Study of Cancer Patients Who Received Cranial Radiation Therapy(SPiRiT) | terminated | — | 5 | Duke UniversityOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT04607135 | ARFI Imaging for Targeted Prostate Biopsy | terminated | N/A | 34 | Duke UniversityOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT04973436 | DBT for Metastatic Lung Cancer(LiveWell) | completed | N/A | 31 | Duke UniversityOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT03064490 | Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED)(PROCEED) | completed | Phase 2 | 35 | Duke UniversityOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT03114553 | Family History in a Singaporean Healthy Population | completed | — | 1,000 | Duke UniversityOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT04639934 | Family History in a Singapore Oncology Population | completed | — | 102 | Duke UniversityOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT05986682 | Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma | completed | — | 30 | Duke UniversityOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT06089967 | Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy(IMBARC) | completed | — | 30 | Duke UniversityOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT04763174 | An mHealth Symptom Management Intervention for Colorectal Cancer Patients (mCOPE) | completed | N/A | 167 | Duke UniversityOTHER | 1 | Jan 16, 2025 | clinicaltrials |
| NCT05674851 | Modeling Organ Motion During Abdominal Imaging in Healthy Volunteers | completed | N/A | 5 | Duke UniversityOTHER | 1 | Jan 6, 2025 | clinicaltrials |
| NCT04736056 | Mindfulness and CBT for Sleep | completed | N/A | 57 | Duke UniversityOTHER | 1 | Dec 2, 2024 | clinicaltrials |
| NCT04808115 | IIT PH1 KDS-1001 in Patients With CML | withdrawn | Phase 1 | 0 | Duke UniversityOTHER | 0 | Nov 26, 2024 | clinicaltrials |
| NCT03109015 | Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing(ASSET) | completed | Phase 2 | 7 | Duke UniversityOTHER | 1 | Oct 8, 2024 | clinicaltrials |
| NCT03823651 | A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP) | completed | N/A | 29 | Duke UniversityOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT04905134 | Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase | completed | N/A | 53 | Duke UniversityOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06038604 | Glioblastoma Psychosocial Support Program | completed | N/A | 11 | Duke UniversityOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT05340322 | Identification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Telemedicine | completed | N/A | 503 | Duke UniversityOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT03134027 | Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers(Immune PDX) | terminated | — | 3 | Duke UniversityOTHER | 1 | Jul 18, 2024 | clinicaltrials |
| NCT04937413 | The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation | completed | Early Phase 1 | 32 | Duke UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT02895841 | Patient-Empowered Mobile Technology in Hospitalized Patients (TRU-PAIN) | completed | N/A | 174 | Duke UniversityOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT02831556 | Point of Care 3D Ultrasound for Various Applications: A Pilot Study | completed | — | 174 | Duke UniversityOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT03516994 | Reducing Disparities in the Quality of Advance Care Planning for Older Adults(EQUALACP) | completed | N/A | 790 | Duke UniversityOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT03719495 | Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer | completed | — | 68 | Duke UniversityOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT04655573 | A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer | terminated | — | 7 | Duke UniversityOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT03859765 | In Person and mHealth Coping Skills Training for Symptom Management and Steps in Stem Cell Transplant Patients(Symptoms-Steps) | completed | N/A | 40 | Duke UniversityOTHER | 1 | Mar 22, 2024 | clinicaltrials |
| NCT03342937 | KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer | completed | Phase 2 | 36 | Duke UniversityOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT04741802 | TOPS for African American Breast Cancer Survivors | completed | N/A | 26 | Duke UniversityOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT02694965 | Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma | completed | — | 122 | Duke UniversityOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT04825912 | Resilience Measurement in Older Adults With Late-Stage Lung Cancer(SST Resilience) | completed | N/A | 18 | Duke UniversityOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT04099836 | Atezolizumab and Bevacizumab in EGFR Mutant NSCLC in Patients With Progressive Disease After Receiving Osimertinib | terminated | Phase 2 | 7 | Duke UniversityOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT04392167 | a/LCI-OCT Pilot in Esophagus | completed | N/A | 37 | Duke UniversityOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT02707471 | Improving Well-Being for Breast Cancer Patients | completed | N/A | 312 | Duke UniversityOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT04563130 | Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer | completed | N/A | 91 | Duke UniversityOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT00734149 | Bortezomib With Melphalan and Prednisone for Multiple Myeloma(MVP) | completed | Phase 2 | 45 | Duke UniversityOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT00944528 | Single Dose Partial Breast Radiotherapy(RSU) | completed | Phase 1 | 35 | Duke UniversityOTHER | 1 | Oct 27, 2023 | clinicaltrials |
| NCT00734513 | Partner-Assisted Emotional Disclosure for GI Cancer | completed | N/A | 300 | Duke UniversityOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT02318095 | Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer | completed | N/A | 40 | Duke UniversityOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT03307525 | Pain After Breast Surgery | completed | — | 141 | Duke UniversityOTHER | 0 | Oct 26, 2023 | clinicaltrials |
| NCT03434418 | A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations | completed | Phase 2 | 17 | Duke UniversityOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT05122247 | Machine Learning to Predict Acute Care During Cancer Therapy(Chemo-SHIELD) | completed | — | 12,000 | Duke UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT03435380 | Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer | completed | N/A | 314 | Duke UniversityOTHER | 1 | Sep 8, 2023 | clinicaltrials |
| NCT04371198 | Patient-Derived Organoids for Rectal Cancer | completed | N/A | 20 | Duke UniversityOTHER | 1 | Aug 28, 2023 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials